Naomi Cretcher

Naomi brings over 15 years of operational experience to biomea fusion. Prior to joining the company, Naomi was one of the first hires at Kartos Therapeutics where she served as Executive Director overseeing operations in the early stages of the company. At Kartos she helped grow operations and established systems and processes. She also was one of the early employees of Pharmacyclics Inc, where she headed the meetings, events and media department which led to 4 FDA labels, with three Breakthrough Therapy Designations within 14 months. She worked closely with CEO and COO on AbbVie’s $21B acquisition of Pharmacyclics; one of the largest biopharma sales ever. Pharmacyclics also received the prestigious Prix Galien for Best Pharmaceutical Agent, which Naomi helped coordinate. Before joining Pharmacyclics, Naomi spent 5 years at Genentech in Medical Communications.